Use of different immunosuppressive strategies in recipients of kidneys from nonheart-beating donors

Autor: Julia Blanco, Ana Sánchez-Fructuoso, Alberto Barrientos, J. Conesa, M. Marques, N. Ridao, A. Rodríguez
Rok vydání: 2005
Předmět:
Zdroj: Transplant International. 18:596-603
ISSN: 1432-2277
0934-0874
DOI: 10.1111/j.1432-2277.2005.00100.x
Popis: Summary In nonheart-beating donor (NHBD) kidney transplants, immunosuppressive management is difficult mainly because of the high incidence of acute tubular necrosis. This has meant that since the start of our NHBD transplant program, several immunosuppression regimes have been used. The aim of this retrospective study was to evaluate the results obtained over 7 years using different treatment protocols. A total of 172 consecutive NHBD transplants performed between April 1996 and December 2002 were treated as follows: G-I (n = 21), cyclosporine (8 mg/kg/day) plus azathioprine plus steroids; G-II (n = 65), low-dose cyclosporine (5 mg/kg/day) plus mycophenolate plus steroids; G-III (n =17), low-dose tacrolimus (0.1 mg/kg/day) plus mycophenolate plus steroids; and G-IV (n = 69), daclizumab plus low-dose tacrolimus plus mycophenolate plus steroids. Delayed graft function rates were 76.2%, 72.3%, 76.5%, and 42%, respectively, for the four groups (P = 0.000). Rejection-free patient rates were 76.2%, 46.2%, 35.3%, and 71% (P
Databáze: OpenAIRE